EVEREST MEDICINES
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in the Emerging Market including Asia Pacific territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in the Emerging Market and have a high probability of market approval. The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in Asia Pacific territories and with leading global pharmaceutical companies.
EVEREST MEDICINES
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.everestmedicines.com
Total Employee:
51+
Status:
Active
Total Funding:
310 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Font Awesome Domain Not Resolving Microsoft Exchange Online Office 365 Mail JsDelivr Microsoft Azure DNS
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
RA Capital Management
RA Capital Management investment in Series C - Everest Medicines
CBC Group
CBC Group investment in Series C - Everest Medicines
Octagon Capital Partners
Octagon Capital Partners investment in Series C - Everest Medicines
Janchor Partners
Janchor Partners investment in Series C - Everest Medicines
Hillhouse Capital Group
Hillhouse Capital Group investment in Series C - Everest Medicines
Jiashan SDIC
Jiashan SDIC investment in Series C - Everest Medicines
Janus Henderson Investors
Janus Henderson Investors investment in Series C - Everest Medicines
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - Everest Medicines
Rock Springs Capital
Rock Springs Capital investment in Series C - Everest Medicines
Decheng Capital
Decheng Capital investment in Series C - Everest Medicines
Key Employee Changes
Date | New article |
---|---|
2022-08-25 | Everest Medicines Announces the Departure of CEO, Kerry Blanchard |
2021-04-15 | Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer |
2021-02-18 | Everest Medicines Appoints Kevin Guo as Chief Commercial Officer |
Official Site Inspections
http://www.everestmedicines.com Semrush global rank: 4.34 M Semrush visits lastest month: 2.63 K
- Host name: 8.218.134.90
- IP address: 8.218.134.90
- Location: Singapore Singapore
- Latitude: 1.2929
- Longitude: 103.8547
- Timezone: Asia/Singapore
- Postal: 18